We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
A Wall Street analysis tracking trends in prescription drugs shows strong growth for some of the industry’s key product areas while revealing less-than-encouraging news for several companies.